Related Experiment Video

Updated: May 27, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Inhibition of CXCL10 release by monomeric C3bi and C4b

Y Takeda1, K Kaneda, F Jimma

  • 1Department of Environmental and Preventive Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. ytakeda@hyo-med.ac.jp

Clinical and Experimental Immunology
|December 3, 2011
PubMed

Insights

Cellulose acetate beads reduce inflammation by generating C3bi and C4b fragments. These fragments inhibit key signaling pathways, including STAT1, thus reducing CXCL10 production in leukocytes.

Area of Science:

  • Biomedical Science
  • Immunology
  • Materials Science

Background:

  • Cellulose acetate (CA) beads are utilized in leucocyte apheresis for treating inflammatory bowel disease.
  • The precise anti-inflammatory mechanisms of CA beads remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the anti-inflammatory effects of CA beads.
  • To identify molecules generated by blood-CA bead interactions that modulate leukocyte function.

Main Methods:

  • Collected and analyzed CA-activated blood medium.
  • Investigated the effects of CA-activated medium on leukocyte function, including chemokine and cytokine production (CXCL10) and STAT1 phosphorylation.
  • Utilized mass spectrometry to identify inhibitory factors.
  • Assessed the impact of purified C3bi and C4b on cellular responses.

Main Results:

  • CA bead pre-treatment significantly reduced lipopolysaccharide (LPS)- or interferon (IFN)-β-induced CXCL10 production and STAT1 phosphorylation.
  • Mass spectrometry identified C3 and C4 fragments as inhibitors of CXCL10 production.
  • Monomeric C3bi and C4b proteins were abundant in CA-activated medium and inhibited IFN-β-induced CXCL10 production and STAT1 phosphorylation.

Conclusions:

  • Monomeric C3bi and C4b, generated by blood-CA bead interaction, potently inhibit STAT1-mediated CXCL10 production.
  • These C3bi and C4b-mediated mechanisms likely contribute to the anti-inflammatory effects observed in CA-based therapies.

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...